Inhalation Sciences Sweden
Business Services · Sweden · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Hälsovägen 7, Huddinge, Stockholm, 141 5...Phone Number
+46705625195Website
www.inhalation.seRevenue
<$5 MillionStock Symbol
ISABIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Inhalation Sciences Sweden
Inhalation Sciences Sweden AB is a contract research organization specializing in inhalation drug development and preclinical research. The company provides services covering formulation, aerosol characterization, pharmacokinetics, toxicology, and respiratory research, using proprietary technologies for precise inhalation exposure and drug delivery studies. It supports pharmaceutical, biotechnology, and life-science companies in developing and evaluating inhaled therapies.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Inhalation Sciences Sweden your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Inhalation Sciences Sweden launches new products
Inhalation Sciences Sweden, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Inhalation Sciences Sweden has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Inhalation Sciences Sweden had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Inhalation Sciences Sweden has new funding data
Earning: See what the market has to say on Inhalation Sciences Sweden recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Inhalation Sciences Sweden
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Inhalation Sciences Sweden is spiking on competitors!
Recommended Actions
Find VP level buyers at Inhalation Sciences Sweden
Find 3 more new buyers
Company Profile Activity
Activity Insights
Inhalation Sciences Sweden is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Inhalation Sciences Sweden is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Inhalation Sciences Sweden.
Inhalation Sciences Sweden financials insights
Gather financial insights about Inhalation Sciences Sweden, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Debt
$1M
2026
Debt
$452K
Inhalation Sciences Sweden Tech Stack
A closer look at the technologies used by Inhalation Sciences Sweden
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Project
Product Management, Intellectual Property, Legal Affairs
Funding
Inhalation Sciences Sweden News & Media
Inhalation Sciences appoints Ulf Wedenberg as Chief Commercial Officer (CCO)
Stockholm, May 27, 2025 - Inhalation Sciences Sweden AB (ISAB) has recruited Ulf Wedenberg as itsInhalation Sciences AB (publ) releases Q3 Report 2024
(Stockholm, Sweden, 20 November, 2024) Inhalation Sciences AB announces that its Q3 Report for 2024 is now available on the company's website. To read the whole report (in Swedish) visit: http://inhalation.se/investors/finansiella-rapporter/ CEO statement Order intake in the third quarter was higher than in the same period last year, although revenues were slightly lower because of weaker order intake in the January-September reporting period. During the third quarter, we continued our strategyInhalation Sciences provides latest status update on ongoing FDA BAA dissolution research project
(Stockholm, 16 October 2024) Inhalation Sciences Sweden AB (ISAB) today releases the latest update on progress in its FDA BAA (Broad Agency Agreement) dissolution collaborative research project evaluating the discriminative power of ISAB’s DissolvIt[®] in comparing drug formulations aimed for administration via inhalation. The project - contract number 75F40122C00197 - was communicated by ISAB on September 15[th], 2022, with updates throughout 2023. ISAB today announces that the deadline for thePublication of positive performance of ISAB’s in vitro module demonstrated in collaboration with Karolinska Institutet
A new publication demonstrates how XposeALI[®], Inhalation Sciences’ in vitro cell-based exposure module, successfully predicted the toxicity of inhaled palladium nanoparticles, an emerging pollutant from motor vehicles, in the lung lining. The study was carried out, and the paper co-authored, by scientists from Karolinska Institutet and the Swedish University of Agricultural Sciences as well as Inhalation Sciences. The paper is published in Frontiers in Medicine (Pulmonary Medicine section). Pa
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Inhalation Sciences Sweden
Sign Up For FreeTo access detailed company insights
Inhalation Sciences Sweden AB is a contract research organization specializing in inhalation drug development and preclinical research. The company provides services covering formulation, aerosol characterization, pharmacokinetics, toxicology, and respiratory research, using proprietary technologies for precise inhalation exposure and drug delivery... Read More
